Anika Therapeutics Inc (NAS:ANIK)
$ 25.5605 0.0005 (0%) Market Cap: 379.02 Mil Enterprise Value: 338.87 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 88/100

Q2 2019 Anika Therapeutics Inc Earnings Call Transcript

Jul 24, 2019 / 09:00PM GMT
Release Date Price: $40.82 (+0.20%)
Operator

Good evening, ladies and gentlemen, and welcome to Anika Therapeutics Second Quarter 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this call may be recorded. I would now like turn the call over to Sylvia Cheung, Chief Financial Officer. Please go ahead.

Sylvia Cheung
Anika Therapeutics, Inc. - CFO, Treasurer & Secretary

Thank you, Katherine. Good evening, everyone, and thank you for joining our second quarter 2019 earnings call. With me on the call today is Anika's President and Chief Executive Officer, Joseph Darling. During today's call, Joe and I will review our second quarter 2019 financial results and key business highlights, which were summarized in our earnings release issued today. A copy of the earnings release is available in the Investor Relations section of our website at anikatherapeutics.com. In addition, a slide presentation is posted on our website in the Investor Relations section under the Events and Presentations tab. We invite you to take a moment to open the file and follow the presentation along with us. Please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot